Virtual Exercise Rehabilitation Treatment Program for Post Exacerbation of Chronic Obstructive Pulmonary Disease

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05045209

Acronym

VERTEX

Enrollment

Registered

2021-09-16

Start date

2022-01-01

Completion date

2023-10-01

Last updated

2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Brief summary

Respiratory rehabilitation is an intervention proven to improve quality of life in those with chronic lung disease but access remains poor. The investigators will assess the feasibility and acceptability of a virtual platform for respiratory rehabilitation as an alternative to in person rehabilitation. The aim is to use the technology in those post admission with COPD where access has been even more of a challenge as during this period patients find it difficult to access an out patient program due to their frailty.

Detailed description

People living with lung disease struggle with activities. An exercise program can help but these programs are limited and are hard to get to and generally have a long wait list. The investigators will offer exercise and education through a tablet with internet provided 2 times per week for 10 weeks for patients admitted to hospital with a worsening of their COPD. Patients will work with a trained therapist for the exercise sessions and with the team for the education sessions. The investigators will assess outcomes on functional and quality of life improvements as well as feasibility and scalability of the technology.

Interventions

OTHERVirtual rehabilitation

Patient who are assigned to this group will receive virtual rehabilitation

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* minimum age of 18 years * maximum age of 90 years * diagnosis of COPD

Exclusion criteria

* inability to perform exercise * severe debilitating conditions

Design outcomes

Primary

Measure	Time frame	Description
6 minute walk test distance	1 year	The distance walked during the 6 minute
1-MSTST	1 year	One-minute sit to stand test

Other

Measure	Time frame	Description
Daily activity levels	1 year	Measured by step counts

Countries

Canada

Contacts

Primary ContactNatya Raghavan, MDCM

raghanat@hhsc.ca905-521-2100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026